Combinatorial Treatment of DNA and Chromatin-Modifying Drugs Cause Cell Death in Human and Canine Osteosarcoma Cell Lines

• Venugopal Thayanithy,

  Affiliation Department of Surgery, University of Minnesota, Minneapolis, Minnesota, United States of America

  ⨯
• ChangWon Park,

  Affiliation Department of Medicine, University of Minnesota, Minneapolis, Minnesota, United States of America

  ⨯
• Aaron L. Sarver,

  Affiliation Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America

  ⨯
• Reena V. Kartha,

  Affiliation Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, United States of America

  ⨯
• Derek M. Korpela,

  Affiliation Department of Veterinary Clinical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America

  ⨯
• Ashley J. Graef,

  Affiliation Department of Veterinary Clinical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America

  ⨯
• Clifford J. Steer,

  Affiliations Department of Medicine, University of Minnesota, Minneapolis, Minnesota, United States of America, Department of Genetics, Cell Biology & Development, University of Minnesota, Minneapolis, Minnesota, United States of America

  ⨯
• Jaime F. Modiano,

  Affiliations Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America, Department of Veterinary Clinical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America

  ⨯
• Subbaya Subramanian

  * E-mail: subree@umn.edu

  Affiliations Department of Surgery, University of Minnesota, Minneapolis, Minnesota, United States of America, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America

  ⨯